For this reason, novel biomarkers, such as the major vault protein (MVP) [55] and CTHRC1 [18], are proposed for use as a more proper detection of HCC circulating cells with a mesenchymal or an intermediate phenotype [55]. The gene discussed is CTHRC1; the disease is hepatocellular carcinoma.